1king B,cmtt R,lonneux M,et al. Role of PET in the initial staging of cutaneous malignant melanoma:systematic review[J]. Radiology, 2008,249 : 836-844.
2Kwee R M. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of ^18F- FDG PET :a systematic review [J]. Radiology, 2010,254:707-717.
3Ahn P H,Garg M K. Positron emission tomography/computed tomography for target delineation in head and neck cancers [J]. Semin Nucl Med ,2008,38:141-148.
2O'connor M K,Kemp B T.single-photon emission computer tomography/computed tomography:basie instrumentation and innovations[J].Semin nucl Med,2006,36:258-266.
3Nomayr A,Rower W,Strobel D,et al.Anatomical accuracy of hybrid SPECT/spiral CT in the lower spine[J].Nuel Med commiun,2006,36:521-528.
6Schmidt M ,BollschweilerE ,Dietlein M ,et al. Mean and maximum standardized uptake values in [^18F] FDG-PET for assessment of histopathological response in oesophageal squamous cell carcinoma or adenocarcinoma after radiochemotherapy[J]. Eur J Nucl Med Mol Imaging,2009,36:735-744.
7Smith J W,Moreira J,Abood G,et 01. The influence of ( 18)fluorodeoxyglueose posit - ron emission tomography on the manage- ment of gastroesophageal junction carcino- ma[J]. Am J Surg,2009,197:308-312.
8McLoughlin J M, Melis M, Siegel E M ,et ol. Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer [J]. J Am Coll Surg, 2008,206 : 879-886.
